EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
CHEBI:CHEBI_62913
Definition
An EC 2.4.2.* (pentosyltransferase) inhibitor that interferes with the action of a NAD(+) ADP-ribosyltransferase (EC 2.4.2.30).
Alternative Names
- ADP-ribosyltransferase (polymerising) inhibitor
- ADP-ribosyltransferase (polymerising) inhibitors
- ADP-ribosyltransferase (polymerizing) inhibitor
- ADP-ribosyltransferase (polymerizing) inhibitors
- EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitors
- EC 2.4.2.30 inhibitor
- EC 2.4.2.30 inhibitors
- NAD(+) ADP-ribosyltransferase (EC 2.4.2.30) inhibitor
- NAD(+) ADP-ribosyltransferase (EC 2.4.2.30) inhibitors
- NAD(+) ADP-ribosyltransferase inhibitor
- NAD(+) ADP-ribosyltransferase inhibitors
- NAD(+):poly(adenosine-diphosphate-D-ribosyl)-acceptor ADP-D-ribosyl-transferase inhibitor
- NAD(+):poly(adenosine-diphosphate-D-ribosyl)-acceptor ADP-D-ribosyl-transferase inhibitors
- NAD(+):poly(ADP-D-ribosyl)-acceptor ADP-D-ribosyl-transferase inhibitor
- NAD(+):poly(ADP-D-ribosyl)-acceptor ADP-D-ribosyl-transferase inhibitors
- PARP
- PARPs
- poly(adenosine diphosphate ribose) polymerase inhibitor
- poly(adenosine diphosphate ribose) polymerase inhibitors
- poly(ADP-ribose) polymerase inhibitor
- poly(ADP-ribose) polymerase inhibitors
- poly(ADP-ribose) synthase inhibitor
- poly(ADP-ribose) synthase inhibitors
- poly(ADP-ribose) synthetase inhibitor
- poly(ADP-ribose) synthetase inhibitors
Drug Classification
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:62913
- oboInOwl#hasDbXref
- Wikipedia:PARP_inhibitor
Additional References
Wikipedia:PARP_inhibitor
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#id
- CHEBI:62913
- core#notation
- CHEBI:62913
- oboInOwl#hasDbXref
- Wikipedia:PARP_inhibitor
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_177298
- owl#someValuesFrom
- t307120
- owl#annotatedSource
- t259481